.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Siemens Healthineers is planning a significant exit from the American Oncology Institute (AOI). This move highlights shifting priorities in cancer care investment India and broader healthcare strategies. The company has reportedly engaged Alvarez & Marsal to manage the multi-crore deal. Currently, AOI operates 16 hospitals across India with a 500-bed capacity.
Siemens considers the AOI hospital network a non-core asset. Therefore, they aim to focus on diagnostic and therapeutic imaging instead. This potential sale aligns with global plans to streamline their portfolio. Bloomberg previously reported talks regarding a $7 billion sale of their diagnostic business. Consequently, the company is refocusing on its primary technological strengths.
The Indian cancer care market shows rapid expansion today. It reached a value of ₹1.25 lakh crore in 2024. Furthermore, analysts expect a CAGR of 10-12% over the coming years. Several private equity funds are showing interest in this acquisition. Healthcare Global Enterprises (HCG) has also been sounded out as a potential bidder. This trend demonstrates high investor confidence in specialized oncology services.
Q1: What is the estimated valuation of the American Oncology Institute deal?
The deal is expected to value the cancer care chain between ₹1,500 and ₹2,000 crore.
Q2: Who is advising Siemens on this transaction?
Investment bank Alvarez & Marsal is currently advising Siemens on the potential sale of AOI.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Siemens Healthineers plans to exit the American Oncology Institute, valuing the chain at ₹2,000 crore. Explore the impacts on India's cancer care market....
5 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
